Vidac Pharma Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 7

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $9M

  • Investors
  • 4

Vidac Pharma General Information

Description

Developer of anti-cancer drugs designed to treat patients with oncologic and dermatologic diseases. The company's drugs are a master regulator of metabolism in proliferating cells that is absent from most normal cells, enabling doctors to monitor patients' metabolic pathways through VDAC/HK2 modulators.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Weizmann Science Park
  • Einstein 18, Post Office Box 4053
  • Ness Ziona 7403622
  • Israel
+972 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vidac Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 29-Jun-2016 $9M 000 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Vidac Pharma’s complete valuation and funding history, request access »

Vidac Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of anti-cancer drugs designed to treat patients with oncologic and dermatologic diseases. The company's drugs
Drug Discovery
Ness Ziona, Israel
7 As of 2022
000
00000000000 000

000000

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mo
0000 000000000
Barcelona, Spain
00 As of 0000
0000
000000000000 0000

000000

tation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
0000000000000
Boston, MA
00 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vidac Pharma Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Venture Capital-Backed Barcelona, Spain 00 0000 000000000000 0000
000000000 000000 Venture Capital-Backed Boston, MA 00 00000 0000000000 0 00000
000 000000000000 Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
00000000 Venture Capital-Backed Boston, MA 00 0000 00000000000 0000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 0000000000
You’re viewing 5 of 10 competitors. Get the full list »

Vidac Pharma Patents

Vidac Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3735402-A1 Methods for preparation of jasmonate compounds Pending 07-Jan-2018 0000000000
EP-3735402-A4 Methods for preparation of jasmonate compounds Pending 07-Jan-2018 0000000000
US-20210078949-A1 Methods for preparation of jasmonate compounds Pending 07-Jan-2018 0000000000
US-11096935-B2 Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses Active 07-Nov-2016 000000000
US-20200188381-A1 Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses Active 07-Nov-2016 A61K31/47
To view Vidac Pharma’s complete patent history, request access »

Vidac Pharma Executive Team (6)

Name Title Board Seat Contact Info
Shuki Cohen Ph.D Chief Financial Officer
Merav Revach Chief Technology Officer
Paul Salama Ph.D Vice President of Chemistry, Manufacturing and Control
Chaim Brickman MD Chief Medical Officer
Max Herzberg Ph.D Founder, Chief Executive Officer & Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

Vidac Pharma Board Members (9)

Name Representing Role Since
Christian Policard Vidac Pharma Board Member 000 0000
Joseph Tenne Self Board Member 000 0000
Max Herzberg Ph.D Self Founder, Chief Executive Officer & Chairman 000 0000
Oren Becker Ph.D Self Board Member 000 0000
Robert Spiegel MD Vidac Pharma Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Vidac Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vidac Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Edward Saltzman Angel (individual) Minority 000 0000 000000 0
Israel Biotech Fund Venture Capital Minority 000 0000 000000 0
Mivtach Shamir Holdings PE/Buyout Minority 000 0000 000000 0
Robert Spiegel Angel (individual) Minority 000 0000 000000 0
To view Vidac Pharma’s complete investors history, request access »